Hansen, K <br/><br/>
Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans.  [electronic resource] 

 -  Acta dermato-venereologica  Aug 1992 
 - 297-300 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0001-5555 
<br/><br/><label>Standard No.: </label>102340/0001555572297300  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Disease Models, Animal<br/>Disease Susceptibility<br/>Erythema Chronicum Migrans--drug therapy<br/>Female<br/>Gerbillinae<br/>Humans<br/>Lyme Disease--drug therapy<br/>Male<br/>Middle Aged<br/>Penicillin V--therapeutic use<br/>Recurrence<br/>Roxithromycin--therapeutic use<br/>Single-Blind Method<br/>Sweden